These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 571799)

  • 21. Tamoxifen aziridines: effective inactivators of the estrogen receptor.
    Robertson DW; Wei LL; Hayes JR; Carlson KE; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 1981 Oct; 109(4):1298-300. PubMed ID: 7285873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketononestrol aziridine, an agonistic estrogen receptor affinity label: study of its bioactivity and estrogen receptor covalent labeling.
    Elliston JF; Zablocki JA; Katzenellenbogen BS; Katzenellenbogen JA
    Endocrinology; 1987 Aug; 121(2):667-76. PubMed ID: 3595536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of estrogens in tissues: a comparison of estrogen receptor in rabbit uterus and vagina.
    Payne DW; Katzenellenbogen JA
    Endocrinology; 1980 May; 106(5):1345-52. PubMed ID: 7363855
    [No Abstract]   [Full Text] [Related]  

  • 24. [Multi-component system of estrogen binding proteins from the liver: characterization of binding properties of high molecular weight protein from rat liver similar to uterine estradiol receptors].
    Mataradze GD; Rukaĭia MKh; Smirnov AN; Rozen VB
    Biokhimiia; 1979 Aug; 44(8):1484-92. PubMed ID: 497294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response.
    Markaverich BM; Clark JH
    Endocrinology; 1979 Dec; 105(6):1458-62. PubMed ID: 574077
    [No Abstract]   [Full Text] [Related]  

  • 26. CDRI-85/287: studies on competition to estrogen binding sites in the immature rat uterus.
    Sreenivasulu S; Dwivedi A; Singh MM; Setty BS; Kamboj VP
    Indian J Exp Biol; 1992 Dec; 30(12):1115-7. PubMed ID: 1294475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific binding of 5 alpha-androstan-3 beta, 17 beta-diol to protein fraction pituitary cytosol of female rats.
    Degtiar VG
    Endocrinol Exp; 1983 Jun; 17(2):145-53. PubMed ID: 6603968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogenic properties of 3,9-dihydroxybenz[a]anthracene, a potential metabolite of benz[a]anthracene.
    Schneider SL; Alks V; Morreal CE; Sinha DK; Dao TL
    J Natl Cancer Inst; 1976 Dec; 57(6):1351-4. PubMed ID: 826653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obstruction of estrogen-receptor complex formation. Further analysis of the nature and steroidal specificity of the effect.
    Watson GH; Korach KS; Muldoon TG
    Endocrinology; 1977 Dec; 101(6):1733-43. PubMed ID: 590188
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evidence of 5 alpha-androstane-3 beta, 6 alpha, 17 beta-triol and of 5 alpha-androstane-3 beta, 7 alpha, 17 beta-triol in the anterior pituitary of the prepuberal male rate].
    Morfin R; Guiraud JM; Ducouret B; Samperez S; Jouan P
    C R Seances Acad Sci D; 1979 Jan; 288(4):437-40. PubMed ID: 109225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of the estrogen receptor in human skin.
    Hasselquist MB; Goldberg N; Schroeter A; Spelsberg TC
    J Clin Endocrinol Metab; 1980 Jan; 50(1):76-82. PubMed ID: 7350189
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo metabolism of 3H-dihydrotestosterone and 3H-androstanediol in adult male rats.
    Van Doorn EJ; Burns B; Wood D; Bird CE; Clark AF
    J Steroid Biochem; 1975; 6(11-12):1549-54. PubMed ID: 1052860
    [No Abstract]   [Full Text] [Related]  

  • 33. Decrease in rat uterine estrogen receptors during aging: physio- and immunochemical properties.
    Gesell MS; Roth GS
    Endocrinology; 1981 Nov; 109(5):1502-8. PubMed ID: 7297488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen receptor activation and the dissociation kinetics of estradiol, estriol, and estrone.
    Weichman BM; Notides AC
    Endocrinology; 1980 Feb; 106(2):434-9. PubMed ID: 7353517
    [No Abstract]   [Full Text] [Related]  

  • 35. Properties of the estrogen receptor in the human oviduct and its interaction with ethinylestradiol and mestranol in vitro.
    Muechler EK; Kohler D
    J Clin Endocrinol Metab; 1980 Nov; 51(5):962-7. PubMed ID: 7419693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: Steroid receptor studies in the dog prostate.
    Evans CR; Pierrepoint CG
    J Endocrinol; 1976 Mar; 68(3):28P-29P. PubMed ID: 176302
    [No Abstract]   [Full Text] [Related]  

  • 37. Estrogen receptor in rat adrenal gland.
    Cutler GB; Barnes KM; Sauer MA; Loriaux DL
    Endocrinology; 1978 Jan; 102(1):252-7. PubMed ID: 743950
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of perinatal triiodothyronine (T3) treatment on thymic glucocorticoid and estrogen receptors and uterus estrogen receptors. Receptor selectivity during hormonal imprinting.
    Csaba G; Inczefi-Gonda A
    Acta Physiol Hung; 1996; 84(1):19-23. PubMed ID: 8993671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5beta-Androstane-3alpha,17beta-diol: an endogenous substrate for rabbit liver 3-hydroxyhexobarbital dehydrogenase.
    Takenoshita R; Toki S
    Biochem Pharmacol; 1978 Mar; 27(6):989-93. PubMed ID: 207285
    [No Abstract]   [Full Text] [Related]  

  • 40. Diethylstilbestrol metabolites and analogs. New probes for the study of hormone action.
    Korach KS; Metzler M; McLachlan JA
    J Biol Chem; 1979 Sep; 254(18):8963-8. PubMed ID: 479173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.